ANXA2 and prostate carcinoma: ANXA2 expression is also reduced or lost in prostate cancer cell lines, such as LNCAP, PC3, and DU145, and so forth, compared with primary normal human prostate; however, overexpression of ANXA2 in DU145 or LNCaP inhibits cell migration [97].